Please login to the form below

Not currently logged in
Email:
Password:

TriCor

This page shows the latest TriCor news and features for those working in and with pharma, biotech and healthcare.

AbbVie is not looking at another big acquisition, says CEO

AbbVie is not looking at another big acquisition, says CEO

Despite a tougher competitive environment Humira continued to grow strongly, with sales up almost 18% to $3.26bn, although the lipid-lowering franchise based on Tricor/TriLipix (fenofibrate) and Niaspan (niacin)

Latest news

  • AbbVie sales jump on strong Humira gains AbbVie sales jump on strong Humira gains

    AbbVie's sales gains came despite the continuing impact of the loss of patent protection for cholesterol-lowering drug TriCor (fenofibrate), which fell 66 per cent to $153m as generic competition

  • AbbVie said to be planning major salesforce cuts in US AbbVie said to be planning major salesforce cuts in US

    start of generic competition to cholesterol-lowering drugs TriCor (fenofibrate) and Niaspan (niacin). ... According to AbbVie's 2012 report, combined sales of TriCor and Trilipix totalled $1.1bn, while Niaspan contributed $911m, with all sales derived

  • Abbott reports flat Q2 net profit

    Cholesterol treatment, TriCor/Trilipix (fenofibrate) also saw improved growth, with sales increasing 15.6 per cent to £388m.

  • Abbott to purchase Solvay pharma

    TriCor uses the active ingredient fenofibrate and accounts for about 20 per cent of Brussels-based Solvay's pharmaceutical sales. ... In 2011 TriCor faces generic competition and Abbott is seeking regulatory approval to market TriLipix in combination

  • Elan and J&JPRD submit NDA for novel Invega reformulation

    Four US marketed products currently use NanoCrystal Technology: lipid-lowering TriCor (fenofibrate), which is marketed by Abbott and Solvay; cachexia treatment Megace ES (megestrol), which is marketed by Par Pharmaceutical; immunosuppressant

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

04 A Healthy Ambience
Creating a Lifeline to the New Digital User...
03 Health Services
How Pharma Companies Can Survive the Patent Cliff Through Digital Innovation...
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...

Infographics